BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34641878)

  • 1. Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance.
    Lv H; Jin S; Zou B; Liang Y; Xie J; Wu S
    Cancer Cell Int; 2021 Oct; 21(1):532. PubMed ID: 34641878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
    Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):740-752. PubMed ID: 38477044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
    Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
    Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.
    Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y
    Front Oncol; 2020; 10():215. PubMed ID: 32158694
    [No Abstract]   [Full Text] [Related]  

  • 5. Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis.
    Luo X; Wei J; Yang FL; Pang XX; Shi F; Wei YX; Liao BY; Wang JL
    Cancer Cell Int; 2019; 19():323. PubMed ID: 31827397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a-3p Enhances Cisplatin Resistance by Regulating Krüppel-Like Factor 4-Mediated Cell Apoptosis and Epithelial-to-Mesenchymal Transition in Cervical Cancer.
    Yang J; Hai J; Dong X; Zhang M; Duan S
    Front Pharmacol; 2021; 12():783213. PubMed ID: 35095494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells.
    Zhou Y; Wang Y; Lin M; Wu D; Zhao M
    Cancer Cell Int; 2021 Jul; 21(1):400. PubMed ID: 34320988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
    Xu Y; Zheng Y; Duan Y; Ma L; Nan P
    Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of non-coding RNAs and their functional network associated with optic nerve invasion in retinoblastoma.
    Sun J; Gan L; Ding J; Ma R; Qian J; Xue K
    Heliyon; 2023 Feb; 9(2):e13813. PubMed ID: 36852072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Genomic Alterations and the circRNA-miRNA-mRNA Regulatory Network in Primary and Recurrent Synovial Sarcomas.
    Yao Q; He YL; Wang N; Dong SS; Tu He Ta Mi Shi ME; Feng X; Chen H; Pang LJ; Zou H; Zhou WH; Li F; Qi Y
    Front Mol Biosci; 2021; 8():707151. PubMed ID: 34485383
    [No Abstract]   [Full Text] [Related]  

  • 16. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
    Zhong Y; Lin H; Li Q; Liu C; Shen J
    Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.
    Li S; Liu X; Li H; Pan H; Acharya A; Deng Y; Yu Y; Haak R; Schmidt J; Schmalz G; Ziebolz D
    J Periodontal Res; 2018 Aug; 53(4):495-505. PubMed ID: 29516510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01018 and SMIM25 sponged miR-182-5p in endometriosis revealed by the ceRNA network construction.
    Jiang L; Zhang M; Wang S; Xiao Y; Wu J; Zhou Y; Fang X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420976309. PubMed ID: 33237828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.